Mochida Pharmaceutical Co., Ltd. Financial Overview
Mochida Pharmaceutical Co., Ltd.'s market cap is currently €635.19M. The company's EPS TTM is €0.30686048; its P/E ratio is 16.00; Mochida Pharmaceutical Co., Ltd. is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
